IVF centre in Goa
Consultations in Panjim · Margao · Mapusa · Vasco
Call
Page 62 of 73Doctor path · Doctors' Textbook
Part B: IVF programme · Day OB-5
Page 62 of 73

PCOS in IVF

On this page you will learn

Principles only. Medicines and doses are decided by the treating specialist for each patient; this page explains principles only.

When PCOS reaches IVF

Most women with PCOS conceive with ovulation induction (pages 18-20). The 2023 international guideline says that, without another clear reason for IVF such as blocked tubes or male factor, IVF could be offered when first- or second-line ovulation induction has failed. With elective single embryo transfer, IVF also lets the team keep twins rare, which is hard to do with gonadotropin ovulation induction.

Source: 2023, International PCOS Network / Monash University (Teede et al.) - International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023 (recommendations 5.7.0.1-5.7.0.2)

The same guideline asks that every woman with PCOS be told about her higher OHSS risk before IVF starts, and that options to reduce it be offered. That conversation belongs to the planning visit, with the risk written in the file.

Source: 2023, International PCOS Network / Monash University (Teede et al.) - International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023 (practice point 5.7.0.3)

The ovary in PCOS behaves differently

A PCOS ovary holds many small antral follicles waiting at the edge of recruitment. Small changes in stimulation can tip it from too little response to far too much. The window between "enough" and "dangerous" is narrow. This is why planning, not rescue, keeps her safe.

Choosing the protocol

The PCOS guideline is careful here. The GnRH antagonist protocol cannot be recommended over the long agonist protocol to improve pregnancy or live birth. It is still recommended for women with PCOS, because it allows a GnRH agonist trigger with freezing of all embryos when needed, which reduces significant OHSS without lowering the cumulative live birth.

Source: 2023, International PCOS Network / Monash University (Teede et al.) - International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023 (practice points 5.7.1.1-5.7.1.2)

The 2025 ESHRE update agrees that the antagonist protocol is recommended for predicted high responders. Either urinary or recombinant FSH may be used; neither has been shown to be superior in PCOS, and added recombinant LH is not routine.

Source: Apr 2026, ESHRE, Human Reproduction 41(4):498-514 - ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025

Source: 2023, International PCOS Network / Monash University (Teede et al.) - International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023 (recommendations 5.7.3.1 and 5.7.4.1)

Trigger and freeze-all thinking

In an antagonist cycle, the PCOS guideline recommends a GnRH agonist trigger with freezing of all suitable embryos when a fresh transfer is not intended or when OHSS risk is raised. In practice, the decision is made on the monitoring scans: the more follicles, the stronger the case. The agonist trigger weakens the luteal phase, so a fresh transfer after it needs special luteal support, decided by the specialist (page 57).

Source: 2023, International PCOS Network / Monash University (Teede et al.) - International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023 (recommendation 5.7.2.1)

Think of the plan as a decision tree written before stimulation: if the scan count stays moderate, a fresh transfer may be possible; if it rises past the unit's limit, the agonist trigger and freeze-all follow. The couple should know this tree in advance, so a freeze-all is not a shock.

Metformin, as a concept

Metformin could be used before and during stimulation when a long agonist protocol is used, to lower the risk of OHSS and miscarriage. With the antagonist protocol, which the guideline prefers, it relies on the agonist trigger and freeze-all instead, and ESHRE 2025 does not recommend metformin as a routine stimulation adjunct in PCOS. Doses and timing are not taught on this page.

Source: 2023, International PCOS Network / Monash University (Teede et al.) - International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023 (recommendations 5.7.5.1-5.7.5.2)

Source: Apr 2026, ESHRE, Human Reproduction 41(4):498-514 - ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025

In vitro maturation (IVM), as a concept

In IVM, oocytes are collected while still immature, with little or no stimulation, and matured in the laboratory before ICSI. The embryos are frozen and transferred later. IVM carries no OHSS risk, but the cumulative live birth is lower than with stimulated IVF. The guideline suggests it only in services with real expertise, and as an option after a previous severe OHSS or when the risk is judged too high.

Source: 2023, International PCOS Network / Monash University (Teede et al.) - International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023 (recommendations 5.7.6.1-5.7.6.5)

At the clinic

On Day OB-5 you follow one PCOS patient's IVF file with the faculty: the risk note at planning, the protocol, the scan counts and the trigger decision. Ultrasound scans are watched only: no trainee holds the probe on a patient (PCPNDT Act).

The lab side

A PCOS cycle can give many oocytes, and some will be immature (page 51). The embryologist will report how many were mature; a large number of immature eggs is a signal for the clinician to review the trigger timing next time, not a lab failure.

Common mistakes

Key points

Check yourself

Answer in your head first, then tap a question to see a short answer. Full model answers are in the faculty guidebook.

1. When does the 2023 PCOS guideline suggest IVF for anovulatory PCOS without another indication?

When first- or second-line ovulation induction has failed.

2. Why is the antagonist protocol recommended in PCOS if it does not raise live birth?

It allows an agonist trigger and freeze-all, which cut severe OHSS without lowering cumulative live birth.

3. When does the guideline recommend an agonist trigger with freeze-all?

In an antagonist cycle when a fresh transfer is not intended or the OHSS risk is raised.

4. Where does metformin fit in PCOS IVF?

It could be used with a long agonist protocol to lower OHSS and miscarriage risk; it is not routine with the antagonist protocol.

5. What is in vitro maturation (IVM), and what is its trade-off?

Immature oocytes collected with little or no stimulation and matured in the lab: no OHSS risk, but a lower cumulative live birth.

6. From page 18: name the three features used to diagnose PCOS in adults.

Irregular or absent ovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology or a raised AMH; two of three, after excluding other causes.

Training note. Training content for registered medical practitioners. Trainees observe all patient care; they do not treat patients during the programme.

Contents and reading plan

Questions on this page

Why is freeze-all common in PCOS IVF?

Freezing all embryos after an agonist trigger greatly lowers the risk of severe OHSS.

What is IVM?

Collecting immature oocytes and maturing them in the lab, with no OHSS risk but lower cumulative live birth.

The Genesis Doctors' Textbook is teaching text for registered medical practitioners on the doctor programmes of the Genesis ART Training Academy. It is not treatment advice and gives no medicine doses; trainees observe all patient care, ultrasound scans are watched only (PCPNDT Act), and bench skills are practised under supervision. Page numbers never change.